Literature DB >> 15612886

Oxazolone-induced murine model of ulcerative colitis.

Xuan Wang1, Qin Ouyang, Wen Jie Luo.   

Abstract

OBJECTIVE: Animal models are useful for studying disease, but there is a shortage of suitable models of ulcerative colitis. The aim of the present study was to set up an oxazolone-induced murine colitis model and use it to research the pathogenesis of inflammatory bowel disease.
METHODS: BALB/c mice were presensitized by painting the skin with 0.2 mL 3% oxazolone in 100% ethanol on days 0 and 1 followed by intrarectal administration of 0.15 mL 1% oxazolone in 50% ethanol on day 7. The disease activity index (DAI), histological changes of the colon, myeloperoxidase (MPO) activity and production of cytokines (TNF-alpha, IL-4, IFN-gamma) by the mucosa were evaluated.
RESULTS: There were obvious changes in the DAI, histology and MPO activity, and the production of interleukin-4 was markedly increased compared with the concentrations of TNF-alpha and IFN-gamma, which remained normal, in the lesions.
CONCLUSION: Oxazolone colitis is Th2-mediated and has similar histologic features and distribution of inflammation to ulcerative colitis (UC), which has important implications for the use of this model in the study of the pathogenesis and treatment of UC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15612886     DOI: 10.1111/j.1443-9573.2004.00173.x

Source DB:  PubMed          Journal:  Chin J Dig Dis        ISSN: 1443-9573


  8 in total

1.  Inflammatory diseases modelling in zebrafish.

Authors:  Camila Idelí Morales Fénero; Alicia Angelina Colombo Flores; Niels Olsen Saraiva Câmara
Journal:  World J Exp Med       Date:  2016-02-20

2.  Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.

Authors:  Valentin Galitovskiy; Jing Qian; Alexander I Chernyavsky; Steve Marchenko; Vivian Gindi; Robert A Edwards; Sergei A Grando
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

3.  Animal Models and Pathogenesis of Ulcerative Colitis.

Authors:  Xin Gao; Jia Li; Xueping Pang; Kaiyuan Cong; Chunlei Jiang; Bingxuan Han; Jiawei Gao; Zhihao Wang; Jiangshan Hu; Kaijun Wen; Xinfa Ye; Liwen Dou
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

4.  Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.

Authors:  Ana Camelo; Jillian L Barlow; Lesley F Drynan; Daniel R Neill; Sarah J Ballantyne; See Heng Wong; Richard Pannell; Wei Gao; Keely Wrigley; Justin Sprenkle; Andrew N J McKenzie
Journal:  J Gastroenterol       Date:  2012-04-27       Impact factor: 7.527

5.  Improvement of Oxazolone-Induced Ulcerative Colitis in Rats Using Andrographolide.

Authors:  Liuhong Zhang; Ning Cao; Yuwen Wang; Youxu Wang; Chao Wu; Xuemei Cheng; Changhong Wang
Journal:  Molecules       Date:  2019-12-24       Impact factor: 4.411

Review 6.  Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease.

Authors:  Brunette Katsandegwaza; William Horsnell; Katherine Smith
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

7.  Persistence of Lgr5+ colonic epithelial stem cells in mouse models of inflammatory bowel disease.

Authors:  Nandini Girish; Cambrian Y Liu; Safina Gadeock; Marie L Gomez; Ying Huang; Zohreh Sharifkhodaei; M Kay Washington; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-14       Impact factor: 4.871

8.  IL-4 Receptor-Alpha Signalling of Intestinal Epithelial Cells, Smooth Muscle Cells, and Macrophages Plays a Redundant Role in Oxazolone Colitis.

Authors:  Jennifer Claire Hoving; Roanne Keeton; Maxine A Höft; Mumin Ozturk; Patricia Otieno-Odhiambo; Frank Brombacher
Journal:  Mediators Inflamm       Date:  2020-01-17       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.